NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
This grant funds clinical trials and biomarker studies aimed at improving stroke treatment, recovery, and prevention.
About this program
The NIH StrokeNet grant supports clinical trials and biomarker studies focused on stroke treatment, recovery, and prevention. It is designed to enhance the understanding of stroke and develop innovative therapies that can improve patient outcomes. The program encourages collaboration among researchers, healthcare providers, and institutions to advance stroke care and research. Eligible applicants include academic institutions, research organizations, and healthcare entities that are engaged in stroke research. The grant aims to foster a network of researchers dedicated to addressing the challenges of stroke through rigorous clinical trials and the exploration of biomarkers that can predict stroke outcomes and recovery. By funding these initiatives, the NIH StrokeNet seeks to translate research findings into practical applications that can benefit patients and healthcare systems.
Eligibility
Academic institutions, research organizations, and healthcare entities engaged in stroke research.